Consumer Health / Over-the-Counter (OTC) Healthcare Products
Strategic Profile
The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip. Haleon announced it is evolving its operating model in support of its Win as One strategy to drive its growth, productivity and culture agenda, with implementation expected by mid-2026, representing a transformation into a world-class consumer company.
Cyborg Score Rationale
Haleon has a compelling financial algorithm of 4-6% annual organic revenue growth and high-single digit adjusted operating profit growth at constant currency enabling strong EPS growth. The company has strong brand portfolio and cost optimization initiatives underway. However, recent stock price weakness suggests market concerns about execution.
Top Insights
Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands and slimming down its manufacturing footprint; the company is well positioned to benefit from industry trends including an aging population and premiumization of consumer healthcare products.
Haleon is driving a step change in its supply chain which will deliver £800m in gross cost savings over the next five years.
The company created a new Chief Growth Officer role with broad responsibility across Category, Marketing, Strategy functions and a new global Commercial Excellence team to leverage its global footprint and brand portfolio strength.
Haleon is reorganizing into six operating units to capitalize on growth opportunities, separating EMEA and LatAm regions and elevating India Subcontinent as a standalone OU.
Named Competitors
Kenvue — Consumer health company spanning OTC medicines and personal care
Hygiene and Health Care — Consumer health and hygiene products portfolio
Recent Developments
(January 2026) Announced operating model evolution with creation of Chief Growth Officer role and reorganization into six operating units to drive growth and agility
(May 2025) Introduced Win as One strategy focused on transforming into a world-class consumer company
(February 2026) Preliminary Full Year Results scheduled for release on 25 February 2026
Open the full interactive Haleon plc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.